Data Sheet FORTEO - Medsafe
forteo-ds-v7.0-28feb14 Page 1 of 13 Data Sheet FORTEO® teriparatide 250 microgram/mL, solution for injection
Download Data Sheet FORTEO - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
(for-TAY-o) User Manual
pi.lilly.com1 FORTEO® (for-TAY-o) teriparatide (rDNA origin) injection User Manual Important: First read the Medication Guide that comes inside your FORTEO carton. Before you use your new FORTEOdelivery device, please read the entire front and back of
Hip Fracture Rehabilitation Protocol - Heywood …
www.heywoodortho.comHip Fracture Rehabilitation Protocol OUTPATIENT or SUBACUTE PHYSICAL THERAPYPHASE I (Weeks 16 postop) Patient is evaluated weekly in outpatient PT unless deemed otherwise, or in inpatient setting
Application Form Instructions - Lilly Cares
www.lillycares.comPP-AP-US-0286 3/2018 ©Lilly USA, LLC 2018. ALL RIGHTS RESERVED. Page 2 If I am a Medicare Part D patient (except Forteo and Taltz patients), I …
REQUEST FOR PRIOR AUTHORIZATION FAX (559) …
www.santehealth.netREQUEST FOR PRIOR AUTHORIZATION FAX (559) 224-2405 or (559) 224-9746 PHONE (559) 228-5400 or (800) 652-2900 O Aqua Therapy O …
2018 Preferred Formulary Changes
www.bcbst.com2018 Preferred Formulary Changes Every year, BlueCross Formularies are reviewed to determine changes based on a drug’s effectiveness, safety, and affordability.